Last10K.com

Mymetics Corp (MYMX) SEC Filing 10-Q Quarterly Report for the period ending Saturday, September 30, 2023

Mymetics Corp

CIK: 927761 Ticker: MYMX
Cover - shares
9 Months Ended
Sep. 30, 2023
Nov. 20, 2023
Cover [Abstract]  
Entity Registrant NameMYMETICS CORPORATION 
Entity Central Index Key0000927761 
Document Type10-Q 
Amendment Flagfalse 
Current Fiscal Year End Date--12-31 
Entity Small Businesstrue 
Entity Shell Companyfalse 
Entity Emerging Growth Companyfalse 
Entity Current Reporting StatusYes 
Document Period End DateSep. 30, 2023 
Entity Filer CategoryNon-accelerated Filer 
Document Fiscal Period FocusQ3 
Document Fiscal Year Focus2023 
Entity Common Stock Shares Outstanding 303,757,622
Document Quarterly Reporttrue 
Document Transition Reportfalse 
Entity File Number000-25132 
Entity Incorporation State Country CodeDE 
Entity Tax Identification Number25-1741849 
Entity Address Address Line 1c/o Mymetics SA 
Entity Address Address Line 2Route de la Corniche 4 
Entity Address City Or TownEpalinges 
Entity Address CountryCH 
Entity Address Postal Zip Code1066 
City Area Code011 
Local Phone Number41 21 566 57 72 
Security 12b TitleCommon Stock, Par Value $0.01 per share 
Trading SymbolMYMX 
Entity Interactive Data CurrentYes 

View differences made from one quarter to another to evaluate Mymetics Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Mymetics Corp.

Continue

Assess how Mymetics Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Mymetics Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue